The ageing population and the expected increase in the number of elderly patients make an evidence-based assessment of Extracorporeal Membrane Oxygenation (ECMO) therapy in old patients progressively more important. Veno-arterial (VA) ECMO results for patient aged <65 years is well known. However, the risk profile and in-hospital prognosis of advanced age patients with ECMO still need more investigation. The aim of this study was to identify risk factors that predicted the outcomes for elderly patients who received VA-ECMO.In this retrospective study, medical records for patients with ECMO aged 65 years and over were collected between 2009 and 2012 at a tertiary hospital.A total of 99 patients (mean age: 76.4±6.4 years) were included. The m...
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) strategy is proposed to reduce the ventilator...
Purpose: To provide an overview and evaluate the performance of mortality prediction models for pati...
Background: Veno-arterial extracorporeal membrane oxygenation (va-ECMO) is a specialized temporary s...
A total of 99 patients (mean age: 76.4±6.4 years) were included. The most common condition requiring...
Background. In most reports on ECMO treatment, advanced age is classified as a contraindication to V...
Background. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) for refractory cardiogenic sh...
Objectives: Because significantly higher mortality is observed in elderly patients undergoing venoar...
Background Use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in elderly patients i...
PURPOSE: Venoarterial extracorporeal membrane oxygenation (V-A ECMO) can be used to support severely...
Extracorporeal membrane oxygenation (ECMO) is a resource- consuming and highly invasive treatment. T...
Background The outcome after veno-venous extracorporeal membrane oxygenation in elderly patients is...
OBJECTIVES:Because significantly higher mortality is observed in elderly patients undergoing venoart...
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) strategy is proposed to reduce the ventilator...
Purpose: To provide an overview and evaluate the performance of mortality prediction models for pati...
Background: Veno-arterial extracorporeal membrane oxygenation (va-ECMO) is a specialized temporary s...
A total of 99 patients (mean age: 76.4±6.4 years) were included. The most common condition requiring...
Background. In most reports on ECMO treatment, advanced age is classified as a contraindication to V...
Background. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) for refractory cardiogenic sh...
Objectives: Because significantly higher mortality is observed in elderly patients undergoing venoar...
Background Use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in elderly patients i...
PURPOSE: Venoarterial extracorporeal membrane oxygenation (V-A ECMO) can be used to support severely...
Extracorporeal membrane oxygenation (ECMO) is a resource- consuming and highly invasive treatment. T...
Background The outcome after veno-venous extracorporeal membrane oxygenation in elderly patients is...
OBJECTIVES:Because significantly higher mortality is observed in elderly patients undergoing venoart...
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) strategy is proposed to reduce the ventilator...
Purpose: To provide an overview and evaluate the performance of mortality prediction models for pati...
Background: Veno-arterial extracorporeal membrane oxygenation (va-ECMO) is a specialized temporary s...